ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart"

  • 2022 American Transplant Congress

    Changes in Diastolic Function and Cardiac Geometry After Pediatric Kidney Transplant: A Longitudinal Study

    K. Sgambat1, S. Clauss2, A. Moudgil1

    1Nephrology, Children's National Hospital, Washington DC, DC, 2Cardiology, Children's National Hospital, Washington DC, DC

    *Purpose: Kidney transplant recipients are at increased risk for cardiovascular disease but systolic function is often preserved and may not reveal cardiac dysfunction until it…
  • 2022 American Transplant Congress

    Marginal Zone B Cells Support T Cell Reconstitution Following ATG Lymphoablation in Heart Allograft Recipients.

    Y. Yamamoto, R. Fan, M. Nicosia, V. Gorbacheva, R. Fairchild, A. Valujskikh

    Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

    *Purpose: Lymphoablation with anti-thymocyte globulin (ATG) is a common therapy in solid organ transplantation. However homeostatic proliferation of pre-existing memory T cells undermines the graft-prolonging…
  • 2022 American Transplant Congress

    The Gut Microbiome in the Critical Care Setting Post-Heart Transplantation

    M. Dela Cruz1, H. Lin2, E. Adler2, M. Khalid2, J. Boissiere2, G. Kim1, S. Pinney1, E. Pamer2, A. Nguyen1

    1Section of Cardiology, University of Chicago, Chicago, IL, 2Duchossois Family Institute, University of Chicago, Chicago, IL

    *Purpose: Given its potential impact on immune activation and systemic inflammation, we aim to investigate gut microbiome compositions and metabolites during critical illness in the…
  • 2022 American Transplant Congress

    Resource Expenditure in the Evaluation of Older Donors for Heart Transplant: An Impediment to Donor Pool Expansion?

    B. Wayda1, J. G. Zaroff2, N. Neidlinger3, P. Geraghty4, R. P. Wood5, J. Nieto5, T. C. Pearson6, B. Nicely7, K. K. Khush1

    1Stanford University School of Medicine, Stanford, CA, 2Kaiser Permanente Northern California, Oakland, CA, 3University of Wisconsin School of Medicine, Madison, WI, 4Donor Network of Arizona, Tempe, AZ, 5LifeGift, Houston, TX, 6Emory University School of Medicine, Atlanta, GA, 7Gift of Life Michigan, Ann Arbor, MI

    *Purpose: Using older donors for heart transplant (HT) could alleviate donor scarcity but the resource implications of this strategy - and whether evaluation of older…
  • 2022 American Transplant Congress

    cDC1-Mediated Prolongation of Cardiac Allograft Survival and Alloantigen Induced Transcriptional Programming

    S. L. Schroth, E. B. Thorp

    Pathology, Northwestern Feinberg School of Medicine, Chicago, IL

    *Purpose: Heart transplantation is currently the only treatment for advanced stage heart failure. While patient survival after transplantation has improved acutely, the same cannot be…
  • 2022 American Transplant Congress

    Derivation of a Cardiac Risk Index for Use in Liver Transplantation for Non-Alcoholic Steatohepatitis

    P. Levy, C. Harrington, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner

    Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Cardiovascular events (CVEs) are the most common cause of early mortality after liver transplant (LT), and LT candidates with non-alcoholic steatohepatitis (NASH) are at…
  • 2022 American Transplant Congress

    Recipient’s Age Does Not Impact Survival After Simultaneous Heart and Kidney Transplant

    F. Aziz1, F. Raza1, S. Parajuli1, T. Hess1, A. Feidler1, D. Mandelbrot2, A. Djamali1, R. Dhingra3

    1University of Wisconsin, Madison, WI, 2UW Health, Madison, WI, 3University of Wisconsin School of Medicine and Public Health, Madison, WI

    *Purpose: Simultaneous heart and kidney transplantation (SHKT) is the treatment of choice for patients who suffer both from end-stage heart and kidney disease. However, the…
  • 2022 American Transplant Congress

    Donor-Derived Cell-Free DNA Across the Spectrum of Solid Organ Transplantation

    S. R. Potter1, J. Miles2, K. Qu2, R. Woodward2, S. Dholakia2

    1Baylor Scott & White Health, Temple, TX, 2CareDx, Inc, Brisbane, CA

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) is a robust and clinically useful analyte initially validated for kidney allograft surveillance. Emerging data support the utility of dd-cfDNA…
  • 2022 American Transplant Congress

    An Updated Estimate of Post-Transplant Survival After Implementation of the New Donor Heart Allocation Policy

    K. A. Lazenby1, N. Narang2, K. M. Pelzer3, G. Ran1, W. F. Parker3

    1Pritzker School of Medicine, University of Chicago, Chicago, IL, 2Advocate Heart Institute, Advocate Christ Medical Center, Chicago, IL, 3Department of Medicine, University of Chicago, Chicago, IL

    *Purpose: Published estimates showing lower post-transplant survival after implementation of the new heart allocation policy may be biased downward due to incomplete follow-up on surviving…
  • 2022 American Transplant Congress

    TNX-1500, an Fc-Modified Anti-cd154 Antibody, Prolongs Nonhuman Primate Cardiac Allograft Survival

    S. Miura1, Z. Abady1, F. Pollok1, M. Ma1, K. Kinoshita1, S. Fogarty2, P. Maguire2, B. Daugherty2, S. Lederman2, R. Pierson III1

    1Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, 2Tonix Pharmaceuticals, Chatham, NJ

    *Purpose: Blockade of the CD40/CD154 T cell costimulation pathway is a promising approach to replace current clinical immunosuppression. TNX-1500 (TNX) is a novel humanized anti-CD154…
  • 1
  • 2
  • 3
  • …
  • 22
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences